Fiera Capital Corp Buys 54,740 Shares of Mettler-Toledo International, Inc. $MTD

Fiera Capital Corp boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 19.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 342,837 shares of the medical instruments supplier’s stock after purchasing an additional 54,740 shares during the period. Mettler-Toledo International comprises 1.4% of Fiera Capital Corp’s portfolio, making the stock its 25th largest holding. Fiera Capital Corp owned about 1.66% of Mettler-Toledo International worth $402,737,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MV Capital Management Inc. raised its stake in Mettler-Toledo International by 50.0% during the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares during the last quarter. ABN Amro Investment Solutions purchased a new stake in Mettler-Toledo International in the second quarter worth about $1,749,000. Candriam S.C.A. raised its stake in shares of Mettler-Toledo International by 0.8% in the second quarter. Candriam S.C.A. now owns 30,191 shares of the medical instruments supplier’s stock worth $35,467,000 after buying an additional 243 shares during the period. Police & Firemen s Retirement System of New Jersey lifted its position in shares of Mettler-Toledo International by 4.8% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 3,175 shares of the medical instruments supplier’s stock valued at $3,730,000 after buying an additional 144 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Mettler-Toledo International by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock valued at $681,489,000 after buying an additional 3,383 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the sale, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,750,875. This represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.94% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have commented on MTD. Bank of America raised their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Stifel Nicolaus increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Monday. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Barclays upped their target price on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a report on Monday. Finally, Citigroup raised their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a report on Monday. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $1,406.50.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,448.86 on Thursday. The company has a market cap of $29.85 billion, a P/E ratio of 36.69, a P/E/G ratio of 4.19 and a beta of 1.41. The firm’s fifty day moving average is $1,330.14 and its two-hundred day moving average is $1,244.83. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,471.07.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the prior year, the firm earned $10.21 EPS. The business’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.